ARDXSMALL

Ardelyx, Inc.

HealthcareBiotechnology
$7.10
$0.00(-0.42%)
52W$3.21
$8.40
Updated May 7, 12:00 AM
RSI70
RS Rating73/99
Beta0.87
Volatility69%
F-Score3/9
Mkt Cap$1.7B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Ardelyx, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 73), indicating performance broadly in line with the market. Earnings growth of 12% provides fundamental context to the price action. Investors should exercise caution due to high volatility (69% annualized), which requires wider risk management.

Relative Strength
73
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.87
vs S&P 500
DEFENSIVE
52W Position
75%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$6.11
50 SMA > 100 SMA$6.43
100 SMA > 150 SMA$6.11
150 SMA > 200 SMA$6.01

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$6.34+11.90%ABOVE
50 SMA$6.11+16.29%ABOVE
100 SMA$6.43+10.46%ABOVE
150 SMA$6.11+16.14%ABOVE
200 SMA$6.01+18.08%ABOVE

Price Performance

1D-0.4%
1W+18.1%
1M+18.9%
3M-3.0%
6M+25.7%
YTD+15.4%
1Y+79.7%
3Y+19.2%
52-Week Trading Range75% from low
$7.10
52W Low$3.21
52W High$8.40

Technical Indicators

RSI (14)BULLISH
69.6
305070
VCP ScoreCOOL
2/10
Base depth: 32.7%

Risk Profile

Beta
0.87
52W Vol
69%
ATR
$0.32
Max DD (1Y)
-40%

Volume Analysis

Today
4.22M
50D Avg
3.51M
Vol Ratio
1.20x
Liquidity
MODERATE

Earnings Momentum

Q2'25-13%
$-0.08
Q3'25-18%
$-0.00
Q4'25-109%
$-0.00
Q1'26+12%
$-0.15
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+32.72%
5 Years:+121.90%
3 Years:+98.40%
TTM:+18.24%

Compounded Profit Growth

10 Years:+14.80%
5 Years:
3 Years:
TTM:-4.77%

Stock Price CAGR

10 Years:+14.58%
5 Years:+33.73%
3 Years:+19.22%
1 Year:+79.75%

Return on Equity

10Y Avg:-64.3%
5Y Avg:-67.0%
3Y Avg:-36.4%
Last Year:-38.1%

Key Metrics

Market Cap$1.7B
Gross Margin89.5%
Net Margin-15.1%
Piotroski F-Score3/9

Frequently Asked Questions

Is ARDX in an uptrend right now?

ARDX has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is ARDX overbought or oversold?

ARDX's RSI (14) is 70. The stock is in neutral territory, neither overbought nor oversold.

Is ARDX outperforming the market?

ARDX has a Relative Strength (RS) Rating of 73 out of 99. ARDX is performing about average compared to the market.

Where is ARDX in its 52-week range?

ARDX is trading at $7.10, which is 85% of its 52-week high ($8.40) and 75% above its 52-week low ($3.21).

How volatile is ARDX?

ARDX has a Beta of 0.87 and 52-week volatility of 69%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.